Ilkka Rauvola
@jukka235.bsky.social
Covid-19. In God we trust, all others must bring data.
X: @jukka235 or https://x.com/jukka235
X: @jukka235 or https://x.com/jukka235
Intellectual disabilities among 7-14 year olds are showing meaningful growth. The total is expected to reach 1% of 7-14 year old population by 2030 and 10% of population by 2048, if current growth continues.
7/x
7/x
November 12, 2025 at 3:10 PM
Intellectual disabilities among 7-14 year olds are showing meaningful growth. The total is expected to reach 1% of 7-14 year old population by 2030 and 10% of population by 2048, if current growth continues.
7/x
7/x
Here is the IQ table for various intellectual disabilities, according to ChatGPT.
6/x
6/x
November 12, 2025 at 11:46 AM
Here is the IQ table for various intellectual disabilities, according to ChatGPT.
6/x
6/x
Among 7-14 year olds, intellectual disabilities (IDs) showing highest patient growth are
- severe IDs (IQ 20-34): 19.2% growth (10x in 13 years)
- unspecified IDs: 18.4% patient growth 18.4% (10x in 14y)
- profound IDs (IQ <20): 16.6% (10x in 15y)
- moderate IDs (IQ 35-49)
5/x
- severe IDs (IQ 20-34): 19.2% growth (10x in 13 years)
- unspecified IDs: 18.4% patient growth 18.4% (10x in 14y)
- profound IDs (IQ <20): 16.6% (10x in 15y)
- moderate IDs (IQ 35-49)
5/x
November 12, 2025 at 11:45 AM
Among 7-14 year olds, intellectual disabilities (IDs) showing highest patient growth are
- severe IDs (IQ 20-34): 19.2% growth (10x in 13 years)
- unspecified IDs: 18.4% patient growth 18.4% (10x in 14y)
- profound IDs (IQ <20): 16.6% (10x in 15y)
- moderate IDs (IQ 35-49)
5/x
- severe IDs (IQ 20-34): 19.2% growth (10x in 13 years)
- unspecified IDs: 18.4% patient growth 18.4% (10x in 14y)
- profound IDs (IQ <20): 16.6% (10x in 15y)
- moderate IDs (IQ 35-49)
5/x
Among 0-6 year olds, the following are showing fastest patient growth:
- unspecified intellectual disabilities (F79): 19.2% average growth (10x in 13 years)
- severe intellectual disabilities (F72): 16.3% average growth (10x in 15 years)
4/x
- unspecified intellectual disabilities (F79): 19.2% average growth (10x in 13 years)
- severe intellectual disabilities (F72): 16.3% average growth (10x in 15 years)
4/x
November 11, 2025 at 10:27 PM
Among 0-6 year olds, the following are showing fastest patient growth:
- unspecified intellectual disabilities (F79): 19.2% average growth (10x in 13 years)
- severe intellectual disabilities (F72): 16.3% average growth (10x in 15 years)
4/x
- unspecified intellectual disabilities (F79): 19.2% average growth (10x in 13 years)
- severe intellectual disabilities (F72): 16.3% average growth (10x in 15 years)
4/x
7-14 and 15-24 year olds are showing the highest levels of intellectual disability. If current growth rates continue, 5 percent of 7-14 and 15-24 year olds will have an intellectual disability diagnosis by 2048 (24 years from now).
3/x
3/x
November 11, 2025 at 9:29 PM
7-14 and 15-24 year olds are showing the highest levels of intellectual disability. If current growth rates continue, 5 percent of 7-14 and 15-24 year olds will have an intellectual disability diagnosis by 2048 (24 years from now).
3/x
3/x
The rise in intellectual disability among <1 year olds also shows in number of diagnoses: up roughly 11 times in 4 years. Also note the rise among 1-6 year olds.
2/x
2/x
November 11, 2025 at 9:16 PM
The rise in intellectual disability among <1 year olds also shows in number of diagnoses: up roughly 11 times in 4 years. Also note the rise among 1-6 year olds.
2/x
2/x
All age groups are showing fairly uniform growth rates. In other words, Finland’s entire population will be affected by specific developmental disorders of speech and language if current growth rates continue.
November 3, 2025 at 10:31 PM
All age groups are showing fairly uniform growth rates. In other words, Finland’s entire population will be affected by specific developmental disorders of speech and language if current growth rates continue.
Reposted by Ilkka Rauvola
There's a similar study of pretty much all of Norway, following up for 3 years after vaccination.
In all years and in the years combined, and in all age cohorts, vaccination was PROTECTIVE against all-causes mortality.
I blogged about it here:
www.someweekendreading.blog/3-takes-covi...
In all years and in the years combined, and in all age cohorts, vaccination was PROTECTIVE against all-causes mortality.
I blogged about it here:
www.someweekendreading.blog/3-takes-covi...
3 Takes on COVID-19 Vaccine Safety
Somebody asked me about safety data for this
fall’s COVID-19 booster vaccinations. Again.
www.someweekendreading.blog
November 2, 2025 at 10:23 PM
There's a similar study of pretty much all of Norway, following up for 3 years after vaccination.
In all years and in the years combined, and in all age cohorts, vaccination was PROTECTIVE against all-causes mortality.
I blogged about it here:
www.someweekendreading.blog/3-takes-covi...
In all years and in the years combined, and in all age cohorts, vaccination was PROTECTIVE against all-causes mortality.
I blogged about it here:
www.someweekendreading.blog/3-takes-covi...
Indeed, patient numbers among children under 1 year old with congenital malformations of the eye and adnexa appear to be increasing.
10/x
10/x
November 2, 2025 at 10:53 PM
Indeed, patient numbers among children under 1 year old with congenital malformations of the eye and adnexa appear to be increasing.
10/x
10/x
Among <1 year olds, it is mainly Other disorders of eye and adnexa (H57) that is responsible for growth in patient numbers in H55-H59. I will check congenital malformations next.
9/x
9/x
November 2, 2025 at 8:04 PM
Among <1 year olds, it is mainly Other disorders of eye and adnexa (H57) that is responsible for growth in patient numbers in H55-H59. I will check congenital malformations next.
9/x
9/x
Among <1 year olds, the subgroup showing fastest patient growth is Other disorders of eye and adnexa (H55-H59), with 21.2% average y/y growth in 2020-2025e, set to reach 10% of <1 population in 22 years at current growth rate.
8/x
chatgpt.com/share/690760...
8/x
chatgpt.com/share/690760...
November 2, 2025 at 1:54 PM
Among <1 year olds, the subgroup showing fastest patient growth is Other disorders of eye and adnexa (H55-H59), with 21.2% average y/y growth in 2020-2025e, set to reach 10% of <1 population in 22 years at current growth rate.
8/x
chatgpt.com/share/690760...
8/x
chatgpt.com/share/690760...
November 2, 2025 at 12:53 PM
The healthy vaccinee effect runs deeper than we may think
What this full national Danish study shows is that a huge effect remains even after correcting for age, sex, comorbidity, medical visits and place of residence
The "unvaccinated by choice" test less (and die earlier)
1/
What this full national Danish study shows is that a huge effect remains even after correcting for age, sex, comorbidity, medical visits and place of residence
The "unvaccinated by choice" test less (and die earlier)
1/
November 2, 2025 at 12:48 PM
Among <1 year olds, patient counts for disorders of conjunctiva (H10-H13) are growing at a 20.7% average rate since 2020. At this rate, the share of all <1 year olds having this diagnosis is set to reach 10% level in 5 years and a 50% level by 2039 (in 14 years).
7/x
chatgpt.com/share/690747...
7/x
chatgpt.com/share/690747...
November 2, 2025 at 12:22 PM
Among <1 year olds, patient counts for disorders of conjunctiva (H10-H13) are growing at a 20.7% average rate since 2020. At this rate, the share of all <1 year olds having this diagnosis is set to reach 10% level in 5 years and a 50% level by 2039 (in 14 years).
7/x
chatgpt.com/share/690747...
7/x
chatgpt.com/share/690747...
Glaucoma (H40-H42) is the only eye related disease subgroup that is not currently showing growth.
6/x
6/x
November 2, 2025 at 11:04 AM
Glaucoma (H40-H42) is the only eye related disease subgroup that is not currently showing growth.
6/x
6/x
Among total population, almost all subsegments of eye related diseases are showing patient growth. With one notable exception: Glaucoma (H40-H42).
5/x
5/x
November 2, 2025 at 10:51 AM
Among total population, almost all subsegments of eye related diseases are showing patient growth. With one notable exception: Glaucoma (H40-H42).
5/x
5/x